Position in INCY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$138,639
+$23,531 QoQ
Shares Held
1,223
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#672
of 849 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Palouse Capital Management, Inc. holds $1,684,394 across 2 Biotechnology names. INCY ranks #2 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,479 | $1,545,755 | |
| 2 | INCY |
Incyte Corp
This page
|
1,223 | $138,639 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,639 | 1,223 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $115,108 | 1,223 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $120,795 | 1,223 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,528,530 | 18,023 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,231,792 | 18,088 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,094,925 | 18,083 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,304,179 | 18,882 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,262,576 | 19,101 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,188,758 | 19,610 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,135,013 | 19,923 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||